William Schaffner: Norovirus is an intestinal virus that can make you very, very sick. It is indelicately called winter vomiting disease, and it begins suddenly, often with an explosive vomit that ...
Dr. Raquel Zemtsov, a physician with UPMC Family Medicine, joined us to talk more about norovirus, its symptoms and how to avoid exposure to it.
An outbreak of norovirus — the virulent, highly contagious stomach illness — has been reported at one of the shelters housing ...
This electron microscope image provided by the Centers for Disease Control and Prevention shows a cluster of norovirus virions ... the back of your hands, under your nails, anything that got ...
Norovirus is surging across the U.S., with case numbers higher now than they've been at the same time in more than a decade, according to the U.S. Centers for Disease Control and Prevention (CDC ...
"The risk is to the very young under age one and the elderly — they can get easily dehydrated. For this there is no real cure other than time." The problem with norovirus is just how contagious ...
Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people worldwide every year, and though there is currently no preventive vaccine, a ...
BOSTON - Massachusetts is seeing an increase in reported norovirus cases this season, according to Department of Public Health data. The number of cases recorded in November and December by the ...
George Sandhu says the diseases are much more serious than a cold and people need to look out for the symptoms ...
The highly contagious norovirus (often referred to as a stomach bug, stomach virus, or stomach flu) is causing illness beyond typical levels seen in previous years. Norovirus symptoms are mainly ...
By Dec. 11, 495 outbreaks of norovirus had been reported nationwide, compared to 393 outbreaks the same time last year, according to the Centers for Disease Control and Prevention. Health experts ...
That may be changing. There are vaccines for norovirus under study. One vaccine by the biotech company HilleVax failed in 2024 to prove its effectiveness in a clinical trial of infants.